2STAHI SM, SHAYEGAN DK. The psychopharmacology of ziprasidone: receptor-binding propreties and real-world psychiatric practice[J]. J Clin Psychiatry, 2003,64 Suppl 19 : 6-12.
3CALEY CF, COOPER CK. Ziprasidone: the fifth atypical antipsychotie[J]. Ann Pharmaeother. 2002, 36(5 ) : 839-851.
4KANE JM. Oral ziprasidone in the treatment of schizophrenia: a review of short-term trials[J]. J Clin Psychiatry, 2003, 64 Suppl 19:19-25.
5HARVEY PD, SIU CO, ROMANO S. Randomized, controlled,double-blind, multicenter comparison of the cognitive effects of ziprasidone versus olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder[J]. Psychopharmacology, 2004, 172(3) :324-332.
6HIRSCH SR, KISSLING W, BAUML J, et al. A 28-week comparison of ziprasidone and haloperidol in outpatients with stable schizophrenia[J]. J Clin Psychiatry, 2002, 63 (6) : 516-523.
7NEMEROFF CB, LIEBERMAN JA, WEIDEN PJ, et al. From clinical research to clinical practive: a d-year review of ziprasidone[J]. CNS Spectr, 2005, 10( 11 ) :s1-s20.
8POTKIN SG, KECK PE Jr, SEGAL S, et al. Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebocontrolled replication trial[J]. J Clin Psyehopharmacol, 2005,25(4) :301-310.
9KANE JM, KHANNA S, RAIADHYAKSHA S, et al. Efficacy and tolerability of ziprasidone in patients with treatment-resistant schizophrenia[J]. Int Clin Psychopharmacol, 2006, 21 ( 1 ) :21-28.
10SIMPSON GM, GLICK ID, WEIDEN PJ, et al. Randomized,controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder[J]. Am J Psychiatry, 2004, 161 (10) : 1837-1847.
3Kahn RS,Fleischhacker WW,Boter H,et al.Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder:an open randomized clinical trial[J].Lancet,2008,371:1085.
